Microbot Medical (MBOT) Downgraded by Zacks Investment Research to Sell

Share on StockTwits

Zacks Investment Research downgraded shares of Microbot Medical (NASDAQ:MBOT) from a hold rating to a sell rating in a research report released on Friday.

According to Zacks, “Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. “

Separately, ValuEngine upgraded Microbot Medical from a hold rating to a buy rating in a research note on Thursday.

Shares of NASDAQ:MBOT traded up $0.15 during mid-day trading on Friday, reaching $6.40. 79,264 shares of the company traded hands, compared to its average volume of 21,161. Microbot Medical has a 52 week low of $6.05 and a 52 week high of $22.80.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings data on Tuesday, August 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.04). sell-side analysts expect that Microbot Medical will post -2.4 earnings per share for the current year.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

Further Reading: Price to Earnings Ratio (PE) Basics

Get a free copy of the Zacks research report on Microbot Medical (MBOT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply